TPO levels in HCC patients showed a delayed increase on POD 5, but remained significantly lower than in mCRC patients (median TPO mCRC = 138.7 pg/ml, median TPO HCC = 74.0 pg/ml, P = 0.031; Fig. 2A). This evidence concerns the gene TPO and hepatocellular carcinoma.